Archives: omnadren 250

omnadren 250

Omnadren 250 ┬áhuman intermediate-acting insulin, produced by recombinant biotechnology using a strain of Saccharomyces cerevisiae. Interacts with the specific receptor of the outer plasma membrane of cells to form insulin-receptor complex stimulates intracellular processes, in Vol. H. The synthesis of a number of key enzymes (hexokinase, pyruvate kinase, glycogen, etc.). The decrease in blood glucose • Read More »